furosemide has been researched along with Esophageal Neoplasms in 3 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Esophageal Neoplasms: Tumors or cancer of the ESOPHAGUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty-nine patients with acute hypercalcemia secondary to carcinoma, myeloma and parathyroid adenoma have been treated with large doses of furosemide, mithramycin, or salmon calcitonin perfusion." | 7.65 | Furosemide, mithramycin, and salmon calcitonin in hypercalcemia. ( Canonne, MA; Deshayes, P; Filastre, JP; Humbert, G; Leroy, J; Maitrot, J, 1975) |
| "Twenty-nine patients with acute hypercalcemia secondary to carcinoma, myeloma and parathyroid adenoma have been treated with large doses of furosemide, mithramycin, or salmon calcitonin perfusion." | 3.65 | Furosemide, mithramycin, and salmon calcitonin in hypercalcemia. ( Canonne, MA; Deshayes, P; Filastre, JP; Humbert, G; Leroy, J; Maitrot, J, 1975) |
| "Furosemide use was not associated with reduced cancer-specific mortality overall (adjusted HR in esophageal cancer = 1." | 1.51 | Furosemide use and survival in patients with esophageal or gastric cancer: a population-based cohort study. ( Cardwell, CR; Coleman, HG; Johnston, BT; Liu, P; McMenamin, ÚC; Spence, AD, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Shiozaki, A | 1 |
| Inoue, H | 1 |
| Shimizu, H | 1 |
| Kosuga, T | 1 |
| Takemoto, K | 1 |
| Kudou, M | 1 |
| Ohashi, T | 1 |
| Arita, T | 1 |
| Konishi, H | 1 |
| Komatsu, S | 1 |
| Kubota, T | 1 |
| Fujiwara, H | 1 |
| Otsuji, E | 1 |
| Liu, P | 1 |
| McMenamin, ÚC | 1 |
| Spence, AD | 1 |
| Johnston, BT | 1 |
| Coleman, HG | 1 |
| Cardwell, CR | 1 |
| Filastre, JP | 1 |
| Humbert, G | 1 |
| Leroy, J | 1 |
| Maitrot, J | 1 |
| Deshayes, P | 1 |
| Canonne, MA | 1 |
3 other studies available for furosemide and Esophageal Neoplasms
| Article | Year |
|---|---|
Cancer Stem Cells of Esophageal Adenocarcinoma are Suppressed by Inhibitors of TRPV2 and SLC12A2.
Topics: Adenocarcinoma; Antineoplastic Agents; Cell Line, Tumor; Esophageal Neoplasms; Furosemide; Humans; N | 2023 |
Furosemide use and survival in patients with esophageal or gastric cancer: a population-based cohort study.
Topics: Aged; Aged, 80 and over; Diuretics; Esophageal Neoplasms; Female; Follow-Up Studies; Furosemide; Hum | 2019 |
Furosemide, mithramycin, and salmon calcitonin in hypercalcemia.
Topics: Adenoma; Adult; Aged; Calcitonin; Carcinoma; Esophageal Neoplasms; Furosemide; Humans; Hypercalcemia | 1975 |